Editor's letter

Welcome to the latest issue of Pharmaceutical Technology Focus magazine

A combination of US government incentives, supply chain disruptions, and geopolitical tensions are prompting increased investment in US manufacturing. In this month's cover story, we spoke to Misumi Americas CEO Dave Evans to learn more about why the US is now a strategic priority for the company.

Also in this issue, we explore how celebrity ambassadors are shifting the nature of direct-to-consumer advertising in the pharma industry, and how US national security priorities are reshaping pharma relationships between the US and China.

Don’t miss our exclusive interview with Swisslog on the key AI governance considerations for the technology's application in the hospital pharmacy.

All this and the latest pharma industry news, comment, and analysis from GlobalData.

Ross Law, Deputy Editor